A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Bortezomib is effective in the treatment of
patients with non-small-cell lung cancer who have not received any prior chemotherapy regimen
for advanced disease.